We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

1 hedge funds and large institutions have $759K invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 174 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 177 → 1 (-176)

100% less capital invested

Capital invested by funds: $944M → $759K (-$943M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 174

Holders
1
Holders Change
-176
Holders Change %
-99.44%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
174
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$94.3M
2
AC
Armistice Capital
New York
-$92.8M
3
RG
Redmile Group
California
-$83.3M
4
DM
Deerfield Management
New York
-$80.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$71.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
51
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$2.39M -152,000 Closed
UOC
52
UBS O'Connor
Illinois
– -$2.39M -151,796 Closed
Wellington Management Group
53
Wellington Management Group
Massachusetts
– -$2.37M -150,873 Closed
AG
54
Algert Global
California
– -$2.06M -130,627 Closed
Citadel Advisors
55
Citadel Advisors
Florida
– -$1.74M -110,550 Closed
CWM
56
CIBC World Markets
New York
– -$1.57M -100,000 Closed
SA
57
Sunesis Advisors
Kansas
– -$1.51M -96,299 Closed
BC
58
BIT Capital
Germany
– -$1.42M -90,000 Closed
Barclays
59
Barclays
United Kingdom
– -$1.39M -88,521 Closed
JAM
60
Jupiter Asset Management
United Kingdom
– -$1.38M -87,543 Closed
TI
61
Trexquant Investment
Connecticut
– -$1.37M -87,256 Closed
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
– -$1.3M -82,708 Closed
Ameriprise
63
Ameriprise
Minnesota
– -$1.28M -81,688 Closed
PP
64
PDT Partners
New York
– -$1.12M -71,297 Closed
Swiss National Bank
65
Swiss National Bank
Switzerland
– -$1.12M -71,200 Closed
MAM
66
Martingale Asset Management
Massachusetts
– -$1.1M -69,926 Closed
Thrivent Financial for Lutherans
67
Thrivent Financial for Lutherans
Minnesota
– -$1.09M -69,575 Closed
VOYA Investment Management
68
VOYA Investment Management
Georgia
– -$1.07M -67,993 Closed
NRD
69
Nebula Research & Development
New York
– -$1.06M -67,645 Closed
Invesco
70
Invesco
Georgia
– -$1.03M -65,578 Closed
Fisher Asset Management
71
Fisher Asset Management
Washington
– -$981K -62,372 Closed
JP Morgan Chase
72
JP Morgan Chase
New York
– -$951K -60,453 Closed
AA
73
AlphaCentric Advisors
Puerto Rico
– -$944K -60,000 Closed
American Century Companies
74
American Century Companies
Missouri
– -$932K -59,247 Closed
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
– -$914K -58,100 Closed
1 2
3
4 5

DCPH Hedge Fund Activity: Q2 2024 in Review

1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q2 2024, worth a combined $759K — down 100% from $944M a quarter earlier.

Sellers outnumbered buyers: 174 funds closed out of DCPH and 0 opened new positions — a net loss of 174 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $94.3M sold.

  • 1 institutional investor held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q2 2024, down from 177 in Q1 2024.
  • Funds reported $759K of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 174 closed out, a net change of -174 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was BlackRock, an estimated $94.3M sold.

Based on aggregated 13F filings for Q2 2024.